Niels Emmerich (Past Speaker)

Niels joined Abbvie in 2011 and has held several positions at AbbVie, including Global Commercial Leader for a late-stage oncology program, Director and Head of Commercial Business Development for Oncology, Senior Director and Head of Search and Evaluation, Oncology, and most recently Vice President and Global Head of Search and Evaluation. Transactions that Niels was involved in in his current and previous role include acquisitions (Pharmacyclics, Stemcentrx), R&D collaborations and license agreements (Argen-X, CytomX, Dong-A-ST, Harpoon, M2Gen, MD Anderson PureMHC, Turnstone, X-Chem,) and venture investments. 

Prior to joining AbbVie Niels was CEO of BioPheresis, co-founder and COO of immatics biotechnologies GmbH, and a strategic management consultant for McKinsey & Company. 

Niels attended University of Tuebingen in Germany and received a Master’s in Biology and a Ph.D. in Immunology.